- ATRA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
Atara Biotherapeutics (ATRA) 10-K/A2014 FY Annual report (amended)
Filed: 6 Mar 15, 12:00am
Exhibit 31.2
CERTIFICATION OF THE CHIEF FINANCIAL OFFICER
PURSUANT TO
SECURITIES EXCHANGE ACT RULES 13A-14(A) AND 15D-14(A)
I, John F. McGrath, Jr., certify that:
1. | I have reviewed this Annual Report on Form 10-K/A of Atara Biotherapeutics, Inc.; and |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
/s/ John F. McGrath, Jr. |
John F. McGrath, Jr. Chief Financial Officer (Principal Financial and Accounting Officer)
|
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.